GT Biopharma, Inc. (GTBP)

0.675 -0.06 (-7.82%) USD  |  NASDAQ  |  Jan 08, 16:00
0.675 0.00 (0.00%) After-Hours: 19:49
More

GT Biopharma Research and Development Expense (Annual): 5.798M for Dec. 31, 2024

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for GTBP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 4.624B
SELLAS Life Sciences Group, Inc. 19.10M
Lyell Immunopharma, Inc. 152.28M
Plus Therapeutics, Inc. 10.58M
Geron Corp. 103.74M